About
Basic Data Updated:
7 days agoIncorporated in the year 1995, Glaxosmithkline Asia Private Limited (GAPL) has been a leading player in the pharmaceutical industry. The company is primarily engaged in the manufacturing of ayurvedic and ‘unani’ pharmaceutical preparations, as well as wholesale trading of perfumes and cosmetics. Additionally, GAPL also offers a range of services such as GSK consumer health care, GSK pain management, GSK oral care, and many more. With its registered office located in Patiala, Punjab, GAPL has established itself as a trusted name in the market. Its commitment to quality and innovation has made it a preferred choice among consumers. The company's focus on research and development has led to the creation of effective and safe products that cater to the diverse needs of its customers. GAPL's success can be attributed to its dedicated team of professionals who work tirelessly to ensure that the company's products and services meet the highest standards. The company's mission to improve the health and well-being of individuals is reflected in its wide range of offerings, which are designed to address various health concerns.
Industry
Company Details
- Location
Patiala, Punjab, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U99999PB1995PTC028476 |
| Company No. | 028476 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 18 Oct 1995 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Chandigarh |
Financials of Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.12% decrease. The company also saw a slight decrease in profitability, with a 7.05% decrease in profit. The company's net worth Soared by an impressive increase of 29.54%.
Corporate Structure
Unlock access to Glaxosmithkline Asia's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Glaxosmithkline Asia Private Limited
Unlock and access historical data on people associated with Glaxosmithkline Asia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(4)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Asia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Annual General Meeting
Glaxosmithkline Asia Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Glaxosmithkline Asia Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
31 Mar 2023Director Appointment
Nitin Mathur was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 30 Jan 2021 & has been associated with this company since 3 years 3 months .
30 Jan 2021Director Appointment
Kanika Shah Wadhwa was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 12 Mar 2019 & has been associated with this company since 5 years 2 months .
12 Mar 2019Director Appointment
Anurita Chopra was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 05 Sep 2016 & has been associated with this company since 7 years 8 months .
05 Sep 2016
Frequently asked questions
What is the Incorporation or founding date of Glaxosmithkline Asia Private Limited?
